Seeking Alpha

Abbott Labs (ABT -0.1%) reaches an $800M settlement with the government to resolve all...

Abbott Labs (ABT -0.1%) reaches an $800M settlement with the government to resolve all outstanding issues regarding an investigation of past sales and marketing practices relating to its neurologic medication Depakote. The settlement stems from a four-year-old investigation into past sales activities, dating as far back as 1998. Additionally, the pharmaceutical giant says it will split into two separately traded companies.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|